Founded in 1998, REVA Medical is developing interventional medical devices that leverage the Company's novel stent designs and biomaterial technologies to improve the treatment of vascular disease.
The Company's flagship product is a bioresorbable drug-eluting stent that will fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product promises to revolutionize the treatment of coronary artery disease.
The Company is also developing an ultra-thin balloon expandable nickel titanium stent that marries the strength and precise delivery of balloon expandable stents with the flexibility of self-expanding stents for the treatment of peripheral artery disease. REVA's unique polymer technology is also being applied to the development of radiopaque, bioresorbable embolic beads for the treatment of uterine fibroids and other applications.
REVA Medical has a broad strategic relationship with Boston Scientific Corporation, the world's leading company in interventional devices. The Company is also certified to the ISO 13485:2003 standard. – less–ZoomInfo